Samantha McLemore - Patient Capital Management
Holding/activity history for CVS Health Corp. (CVS)
← All CVS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,357,159 | 3.63 | Add 10.21% | 0.34 | $69.51–83.93 · VW $78.91i | $97,471,170 | SEC |
| 2025 Q4 | 1,231,416 | 3.77 | Reduce 0.68% | 0.03 | $70.69–84.00 · VW $76.40i | $97,725,148 | SEC |
| 2025 Q3 | 1,239,894 | 3.74 | Reduce 0.16% | <0.01 | $61.19–85.15 · VW $74.83i | $93,475,577 | SEC |
| 2025 Q2 | 1,241,924 | 3.87 | Reduce 6.31% | 0.29 | $58.35–72.51 · VW $64.32i | $85,667,945 | SEC |
| 2025 Q1 | 1,325,638 | 4.62 | Add 2.10% | 0.09 | $53.36–71.45 · VW $63.84i | $89,811,996 | SEC |
| 2024 Q4 | 1,298,429 | 2.69 | Add 68.83% | 1.10 | $43.56–63.33 · VW $54.46i | $58,286,461 | SEC |
| 2024 Q3 | 769,096 | 2.37 | Add 3.97% | 0.09 | $54.81–67.80 · VW $59.69i | $48,360,744 | SEC |
| 2024 Q2 | 739,709 | 2.32 | Add 29.19% | 0.52 | $52.77–63.92 · VW $59.01i | $43,687,207 | SEC |
| 2024 Q1 | 572,574 | 2.22 | Reduce 4.73% | 0.12 | $66.75–80.75 · VW $71.74i | $45,668,474 | SEC |
| 2023 Q4 | 600,977 | 2.52 | Reduce 0.68% | 0.02 | $64.41–83.25 · VW $74.01i | $47,453,109 | SEC |
| 2023 Q3 | 605,120 | 2.49 | Buy | 2.49 | $64.62–77.38 · VW $70.34i | $42,249,505 | SEC |
Price snapshot:
Current price$105.90
Avg. buy price$59.56
+/- since buy77.79%
52-week low$57.05
52-week high$106.39